Latest Update on HER2-Low Breast Cancer and Implications for Clinical Practice

Keeping Current CME

English - December 12, 2023 16:59 - 20 minutes - 28.4 MB - ★★★★ - 22 ratings
Science Health & Fitness Medicine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: From Symptom to Solution: Best Practices in Syndromic Testing for Improved Patient Outcomes

Next Episode: Emerging Antibody-Drug Conjugates in Breast Cancer: An Expert Analysis of Promising Therapies

Did you know that patients with HER2-low metastatic breast cancer now have approved treatment options? Join for a discussion on trial data and testing.

Credit available for this activity expires: 12/5/24
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999024?ecd=bdc_podcast_libsyn_mscpedu